Cancer Metastasis
A section of Cancers (ISSN 2072-6694).
Section Information
Tumor metastasis is one of the hallmarks of cancer and is considered to be the main cause of death for most cancer patients. The process of metastasis is very complex as the characteristics of invading tumor cells are driven by various epigenetic and genetic changes. It is well known that the primary tumors are different than metastatic tumors, hence presenting challenges in treatment as most of the treatment is directed towards the primary tumor. What role immune cells play with invading metastatic tumor cells is not well understood. Therefore, understanding how the tumor microenvironment interacts and allows the invading tumor cells to establish at a distant site is important for unravelling the mechanism of metastasis. Thus, identifying potential molecular targets in the process of metastasis is critical before making any therapeutic interventions.
Keywords
- Tumor metastasis
- Tumor microenvironment
- Hypoxia
- Extravasation of tumor cells
- Tumor heterogeneity
- Tumor derived exosomes
- Cancer associated fibroblasts
- Angiogenesis
- Warburg effect
- Immune checkpoints
- Regulatory and suppressive immune cells
- Cancer therapeutics
- Targeted therapy
- Drug repurposing
- Drug resistance
- Cancer cell metabolism
- Combination therapy
- Metastasis models
- Extracellular matrix
- Metastasis related targets
- Biomarkers
- Clinical trials
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Advances in Metastatic Prostate Cancer (Deadline: 30 April 2024)
- Advances in Metastatic Non-small Cell Lung Cancer–Implications on Diagnosis and Treatment as We Head towards 2024 (Deadline: 31 May 2024)
- Regulators of Breast Cancer Metastasis (Deadline: 30 June 2024)
- Bone and Spine Metastases (Deadline: 30 June 2024)
- Advances in Locally Advanced and Metastatic Kidney Cancer (Deadline: 4 July 2024)
- Advances in the Multidisciplinary Management of Hepatocellular Carcinoma (Deadline: 20 July 2024)
- Exosomes in Cancer Metastasis (Deadline: 25 July 2024)
- Cancer Cells Fostered Microenvironment in Metastasis (Deadline: 25 August 2024)
- Gastric Cancer Metastases (Deadline: 31 August 2024)
- “Cancer Metastasis” in 2023–2024 (Deadline: 31 August 2024)
- Breast Cancer Brain Metastasis and Leptomeningeal Disease (Deadline: 15 September 2024)
- Molecular Pathways in Metastasis of Lung Cancer (Deadline: 30 September 2024)
- Recent Advances and Breakthroughs in Cancer Treatment and Bone Metastasis (Deadline: 30 September 2024)
- Metastatic Cutaneous Neoplasms and Not Only: Current Knowledge and Perspectives (Deadline: 5 October 2024)
- The Role of Neutrophils in Tumor Progression and Metastasis (Deadline: 20 October 2024)
- Advances in Novel Therapeutics in Metastatic Colorectal Cancer (Deadline: 15 November 2024)
- Chemotherapy and Treatment: Metastasis of Colorectal Cancer (Deadline: 20 November 2024)
- Lectins in Cancer (Deadline: 25 November 2024)
- Novel Insights into Glioblastoma and Brain Metastases (Deadline: 31 December 2024)
- Pathophysiology, Diagnosis, and Multidisciplinary Management of Bone Metastases (Deadline: 31 December 2024)
- The Role of Epithelial-Mesenchymal Transition in Therapies Resistance and Cancer Metastasis (Deadline: 19 January 2025)
- Head and Neck Cancer Metastases (Deadline: 1 February 2025)
- Irreversible Electroporation for Liver Metastases from Colorectal Cancer (Deadline: 5 March 2025)
- Cancer Cell Motility (Deadline: 31 March 2025)
- Educating Recent Updates on Metastatic Non-small Cell Lung Cancer (Deadline: 30 June 2025)
Topical Collection
Following topical collection within this section is currently open for submissions:
